Pluri Inc PLUR

Healthcare Biotechnology

Pluri Inc., formerly known as Pluristem Therapeutics Inc., is an Israel-headquartered company engaged in the research and provision of cell-based products directed for a range of industries. The Company is focused on researching and developing cell transformation and 3D cell expansion technologies that allow mass production of cells. The products of the Company are used for the pharmaceutical industry as well as for food technology, agriculture technology, and cell-based materials. In the pharmaceutical sector, the Company's preclinical and clinical programs explore multiple therapeutic areas such as vascular disease, inflammation-related conditions, muscle injuries, and hematological disorders. In the food sector, the Firm produces cultivated meat, cultivated fish, and seafood, as well as plant-based products. In agriculture, the Company develops alternative farming methods. The Company has a portfolio of over 140 granted patents in approximately 52 countries.

NDAQ:PLUR - Post by User

Pluri Inc

<< Previous

Bullboard Posts

Next >>

(76)
•••

Post by lucaM1on Jul 06, 2022 4:06am

300 Views

Post# 34804176

Effective Cell Therapy for Cocaine Addiction

Pluristem's Placenta-Derived Mesenchymal-like Adherent Stromal Cells as an Effective Cell Therapy for Cocaine Addiction in a Rat Model

https://www.pluristem.com/wp-content/uploads/2022/07/pharmaceutics-14-01311-v2.pdf

<< Previous

Bullboard Posts

Next >>

NSXA Acquisition, Gold Volatility & Global Trends | The Market this Month, Ep 10 of 2025